Burney Co. Takes $3.26 Million Position in Envista Holdings Corporation $NVST

Burney Co. purchased a new position in shares of Envista Holdings Corporation (NYSE:NVST) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 128,541 shares of the company’s stock, valued at approximately $3,261,000. Burney Co. owned approximately 0.08% of Envista at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the last quarter. Allworth Financial LP raised its stake in shares of Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after purchasing an additional 776 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after purchasing an additional 949 shares in the last quarter. Finally, IFP Advisors Inc grew its stake in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after purchasing an additional 1,071 shares in the last quarter.

Analyst Ratings Changes

Several analysts have issued reports on NVST shares. Citigroup assumed coverage on Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective on the stock. Morgan Stanley lifted their target price on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Robert W. Baird boosted their price target on Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Evercore reissued an “outperform” rating and set a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. Finally, Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Six research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $28.67.

Envista Trading Down 1.3%

NYSE:NVST opened at $27.16 on Wednesday. The firm has a market capitalization of $4.42 billion, a P/E ratio of 66.25, a P/E/G ratio of 1.56 and a beta of 0.86. The business has a 50 day simple moving average of $24.87 and a 200 day simple moving average of $25.37. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. The firm had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.03 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The firm’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period last year, the company earned $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities research analysts predict that Envista Holdings Corporation will post 1.42 EPS for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.